−0.020CAD
−929.07 KCAD
5.40 M
About GENETETHER THERAPEUTICS INC.
Sector
Industry
CEO
Roland Boivin
Website
Headquarters
Kelowna
Founded
2018
FIGI
BBG014XHHT68
GeneTether Therapeutics, Inc. is a genetic medicines company, which engages in the creation of gene editing therapies based on the GeneTether platform. The company was founded by Daren Graham, William J. Garner, and R. Geoffrey Sargent on February 12, 2018 and is headquartered in Kelowna, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of GTTX is 0.045 CAD — it has increased by 50.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange GENETETHER THERAPEUTICS INC. stocks are traded under the ticker GTTX.
GTTX stock is 33.33% volatile and has beta coefficient of −2.65. Check out the list of the most volatile stocks — is GENETETHER THERAPEUTICS INC. there?
Yes, you can track GENETETHER THERAPEUTICS INC. financials in yearly and quarterly reports right on TradingView.
GTTX net income for the last quarter is −430.70 K CAD, while the quarter before that showed −36.99 K CAD of net income which accounts for −1.06 K% change. Track more GENETETHER THERAPEUTICS INC. financial stats to get the full picture.
Today GENETETHER THERAPEUTICS INC. has the market capitalization of 1.09 M, it has increased by 50.00% over the last week.
No, GTTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GTTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENETETHER THERAPEUTICS INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENETETHER THERAPEUTICS INC. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENETETHER THERAPEUTICS INC. stock shows the neutral signal. See more of GENETETHER THERAPEUTICS INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.